KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$392.0 million.

  • Bristol Myers Squibb's Deferred Taxes rose 5044.25% to -$392.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$965.0 million, marking a year-over-year increase of 5380.56%. This contributed to the annual value of -$965.0 million for FY2025, which is 5380.56% up from last year.
  • Bristol Myers Squibb's Deferred Taxes amounted to -$392.0 million in Q4 2025, which was up 5044.25% from -$359.0 million recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Deferred Taxes peaked at $223.0 million during Q1 2025, and registered a low of -$1.3 billion during Q4 2023.
  • For the 5-year period, Bristol Myers Squibb's Deferred Taxes averaged around -$523.6 million, with its median value being -$492.5 million (2023).
  • Its Deferred Taxes has fluctuated over the past 5 years, first surged by 22830.19% in 2021, then tumbled by 191562.5% in 2022.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Deferred Taxes stood at -$1.3 billion in 2021, then surged by 50.71% to -$624.0 million in 2022, then tumbled by 112.66% to -$1.3 billion in 2023, then soared by 40.39% to -$791.0 million in 2024, then soared by 50.44% to -$392.0 million in 2025.
  • Its last three reported values are -$392.0 million in Q4 2025, -$359.0 million for Q3 2025, and -$437.0 million during Q2 2025.